Lisata Therapeutics Inc (LSTA)

[whirlybird]

Less frustrating here

Finally there is a partnership that makes sense from the standpoint of being non-dilutive. CBMG will pay for the P2 hepatocellular study costs except for licensing fees. I would expect a similarly structured partnership to follow the PreSERVE results. It makes little sense for financially strapped NBS to initiate one study after another if it has to pay for the many studies now pending themselves.